Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Lacy

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
JAMA Network Open|January 12, 2021
Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal CancerKishan K Patel, Stacey Stein, Jill Lacy, et al.
International Journal of Cancer|February 16, 2006
Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID miceJill Lacy, Regina Loomis, Susan Grill, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 2, 2021
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer DatabaseJohannes Uhlig, Michael Cecchini, Amar Sheth, et al.
Archives of Pathology & Laboratory Medicine|May 5, 2022
An Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Tertiary Care Medical CenterJeff D Wang, Christopher Sebastian, Zenta Walther, et al.
Neuro-Oncology|May 27, 2006
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literatureVanita Noronha, Nancy Berliner, Karen K Ballen, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Clinical outcomes of first line FOLFIRINOX <i>vs.</i> gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital SystemTimil Patel, Joseph Miccio, Michael Cecchini, et al.
Scientific Reports|December 17, 2024
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasmsJohannes Uhlig, James Nie, Joanna Gibson, et al.
Annals of Surgical Oncology|January 30, 2019
Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer DatabaseJohannes Uhlig, Cortlandt M Sellers, Charles Cha, et al.
Medical Oncology (Northwood, London, England)|December 29, 2012
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicityKrishna S Gunturu, Xiaopan Yao, Xiangyu Cong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 18, 2018
Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipientWhitney Fu, Jonathan Merola, Maricar Malinis, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
JAMA Network Open|January 12, 2021
Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal CancerKishan K Patel, Stacey Stein, Jill Lacy, et al.
International Journal of Cancer|February 16, 2006
Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID miceJill Lacy, Regina Loomis, Susan Grill, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 2, 2021
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer DatabaseJohannes Uhlig, Michael Cecchini, Amar Sheth, et al.
Archives of Pathology & Laboratory Medicine|May 5, 2022
An Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Tertiary Care Medical CenterJeff D Wang, Christopher Sebastian, Zenta Walther, et al.
Neuro-Oncology|May 27, 2006
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literatureVanita Noronha, Nancy Berliner, Karen K Ballen, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Clinical outcomes of first line FOLFIRINOX <i>vs.</i> gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital SystemTimil Patel, Joseph Miccio, Michael Cecchini, et al.
Scientific Reports|December 17, 2024
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasmsJohannes Uhlig, James Nie, Joanna Gibson, et al.
Annals of Surgical Oncology|January 30, 2019
Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer DatabaseJohannes Uhlig, Cortlandt M Sellers, Charles Cha, et al.
Medical Oncology (Northwood, London, England)|December 29, 2012
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicityKrishna S Gunturu, Xiaopan Yao, Xiangyu Cong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 18, 2018
Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipientWhitney Fu, Jonathan Merola, Maricar Malinis, et al.
Pageof 6